Stocks · Korea 191420 KOSDAQ

Tego Science

7,100원 -0.70% Market cap 576억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR1.13x
EPS0 KRW
BPS6,308 KRW
ROE-17.33%
DPS0 KRW

Returns and 52-week range

1W-1.66%
1M-5.96%
3M-3.27%
6M-44.44%
1Y-62.11%
YTD-54.92%
52W high18,800원
52W low5,230원
From 52W high-62.23%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
202277억2억3억2.7%
202378억-12억-23억-15.3%
202468억-22억33억-33.0%
202559억-44억-70억-74.5%
Quarterly
2024 4Q16억-11억-13억-68.3%
2025 1Q13억-9억-7억-67.7%
2025 2Q16억-5억-3억-28.6%
2025 3Q16억-10억-10억-59.0%
2025 4Q14억-21억-50억-152.2%
2026 1Q12억-19억-20억-155.8%

Company

CEO전세화
Founded2001-03-20
Fiscal year end12
Address: 서울특별시 강서구 마곡중앙8로 93 (마곡동, 테고사이언스)

Peers in the same sector

CompanyMarket capP/EP/B1M
쿼드메디슨580억—1.86+2.86%
진양제약568억2.200.35+0.00%
유유제약605억7.800.54+0.92%
에이프로젠554억—0.28+3.85%
HLB파나진621억—0.86+21.79%
화일약품542억—0.26-29.92%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.